+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men



Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men



Bmc Pharmacology and Toxicology 14: 52



1,3-dimethylamylamine (DMAA) has been a component of dietary supplements and is also used within "party pills," often in conjunction with alcohol and other drugs. Ingestion of higher than recommended doses results in untoward effects including cerebral hemorrhage. To our knowledge, no studies have been conducted to determine both the pharmacokinetic profile and physiologic responses of DMAA. Eight men reported to the lab in the morning following an overnight fast and received a single 25 mg oral dose of DMAA. Blood samples were collected before and through 24 hours post-DMAA ingestion and analyzed for plasma DMAA concentration using high-performance liquid chromatography-mass spectrometry. Resting heart rate, blood pressure, and body temperature was also measured. One subject was excluded from the data analysis due to abnormal DMAA levels. Analysis of the remaining seven participants showed DMAA had an oral clearance of 20.02 ± 5 L∙hr⁻¹, an oral volume of distribution of 236 ± 38 L, and terminal half-life of 8.45 ± 1.9 hr. Lag time, the delay in appearance of DMAA in the circulation following extravascular administration, varied among participants but averaged approximately 8 minutes (0.14 ± 0.13 hr). The peak DMAA concentration for all subjects was observed within 3-5 hours following ingestion and was very similar across subjects, with a mean of ~70 ng∙mL⁻¹. Heart rate, blood pressure, and body temperature were largely unaffected by DMAA treatment. These are the first data to characterize the oral pharmacokinetic profile of DMAA. These findings indicate a consistent pattern of increase across subjects with regards to peak DMAA concentration, with peak values approximately 15-30 times lower than those reported in case studies linking DMAA intake with adverse events. Finally, a single 25 mg dose of DMAA does not meaningfully impact resting heart rate, blood pressure, or body temperature. NCT01765933.

(PDF emailed within 0-6 h: $19.90)

Accession: 055001240

Download citation: RISBibTeXText

PMID: 24090077

DOI: 10.1186/2050-6511-14-52


Related references

Effects of physiological covariables on pharmacokinetic parameters of clomipramine in a large population of cats after a single oral administration. Journal of Veterinary Pharmacology and Therapeutics 30(2): 116-126, 2007

Pharmacokinetic behavior of gentiopicroside from decoction of Radix Gentianae, Gentiana macrophylla after oral administration in rats: a pharmacokinetic comaprison with gentiopicroside after oral and intravenous administration alone. Archives of Pharmacal Research 30(9): 1149-1154, 2007

Pharmacokinetic of 5 components after oral administration of Fructus Forsythiae by HPLC-MS/MS and the effects of harvest time and administration times. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 993-994: 36-46, 2016

A physiological and system analysis of hybrid pharmacokinetic model to characterize carbon tetrachloride blood concentrations following administration in different oral vehicles. Journal of Pharmacokinetics & Biopharmaceutics 21(5): 551-574, 1993

Pharmacokinetic data distinguish abusive versus dietary supplement uses of 1,3-dimethylamylamine. Annals of Emergency Medicine 61(6): 718-719, 2013

Pharmacokinetic study and side effects of chronic daily administration of oral etoposide. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2005-2009, 1992

Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor. Nicotine and Tobacco Research 16(1): 18-25, 2014

Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects. Drug Development and Industrial Pharmacy 40(1): 1-8, 2014

Combined pharmacokinetic and urodynamic study of the effects of oral administration of phenylpropanolamine in female Beagle dogs. Veterinary Journal 184(2): 201-207, 2010

The nutritive value and physiological effects of xylose oral administration to the albino rat. 1950

A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril. Investigational New Drugs 11(1): 17-27, 1993

Comparison of the effects of repeated oral versus subcutaneous fenfluramine administration on rat brain monoamine neurons: pharmacokinetic and dose-response data. Pharmacology, Biochemistry, and Behavior 39(4): 963-969, 1991

Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral administration in Turkeys. Journal of Veterinary Pharmacology and Therapeutics 34(2): 202-205, 2011

Pharmacokinetic evaluation of pamidronate after oral administration: A study on dose proportionality, absolute bioavailability, and effect of repeated administration. Calcified Tissue International 53(5): 297-300, 1993